Abstract:If one reviews the literature with zeal, it is increasingly apparent that few organs escape recruitment when IBD is chronic or progressive. Insights into mucosal pathophysiology have helped with understanding the more frequent extraintestinal manifestations, but the mechanisms attendant to the development of less common events (e.g. acute pancreatitis, concurrent gluten sensitive enteropathy, or active pulmonary disease) remain either poorly studied or obscure. It is particularly interesting, however, to read reports of abnormal pulmonary function, generally of the obstructive type, correlated to measurements of abnormal intestinal permeability in patients with either active pulmonary sarcoid or pulmonary involvement in Crohn's disease. It has been further speculated that similarities in the mucosal immune system of the lung and intestine are responsible for evidence of bronchial hyperreactivity in patients with active IBD. Finally, it is important to recognize that extensions of the inflammatory process are not restricted to the development of organ-based events but may be responsible for some of the most frequent systemic abnormalities detected in IBD patients. It is now also well confirmed that the cytokine environment in IBD can support activated coagulation and, in some clinical situations, overt vascular thrombosis. The cerebrovascular complications of IBD are well recognized and range from peripheral venous thrombosis to central stroke syndromes and pseudotumor cerebri. Reports of focal white matter lesions in the brains of patients with IBD or an increased incidence of polyneuropathy may be other clinical examples of regional microvascular clotting. Microvascular injury appears to be more ubiquitously present, with reports ranging from a speculated primary causative role (e.g., granulomatous vasculitis in the mesenteric circulation) to the utility of nailbed vasospasm, in Crohn's disease, as a clinical marker for disease activity. It is also reported that IL-6 suppression of erythropoietin production is a major feature of the chronic anemia seen in active IBD. Moreover, the capacity of peripheral monocytes from active IBD patients to secrete TNF and IL-8 is reported predictive for the degree of therapeutic response from recombinant erythropoietin. These collected observations constitute another excellent example of the symmetry between basic science and clinical utility. It is from the context of applied basic science that many future therapies will arise. Empiricism will lose much of its appeal as clinical observations will be increasingly translated into cellular language. Already in animal models, elemental diets diminish IL-6-related acute inflammatory injury, and reductions in dietary lipid alter the antigenicity of bacteria. Provocatively, in humans, unconfirmed reports have even associated diet therapy with the resolution of uveitis and pyoderma gangrenosum. It is likely that efforts will also be made to induce oral tolerance if specific triggering proteins are discovered or to alter bowel flora if such an arcane area of investigation becomes resurgent.

Acute small intestinal inflammation results in persistent lymphatic alterations

Mesenteric Lymphatic Alterations Observed During DSS Induced Intestinal Inflammation Are Driven in a TLR4-PAMP/DAMP Discriminative Manner

Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease

Persistence of Lgr5+ Colonic Epithelial Stem Cells in Mouse Models of Inflammatory Bowel Disease.

Characteristics of Intestinal Lamina Propria Dendritic Cells in a Mouse Model of Postinfectious Irritable Bowel Syndrome

The effect of oral tolerance on the roles of small intestinal intraepithelial lymphocytes in murine colitis induced by dextran sodium sulfate

Disturbance of intraepithelial lymphocytes in a murine model of acute intestinal ischemia/reperfusion

The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease

Synergy between intraepithelial lymphocytes and lamina propria T cells drives intestinal inflammation during infection

The role of CD19+ CD5+ CD1dhi B cells in dextran sulfact sodium (DSS)

Segmental regulation of intestinal motility by colitis and the adaptive immune system in the ileum and colon

Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease

Extraintestinal considerations in inflammatory bowel disease

Transfer of CD11c+ lamina propria mononuclear phagocytes from post-infectious irritable bowel syndrome causes mucosal barrier dysfunction and visceral hypersensitivity in recipient mice

Mesenteric Organ Lymphatics and Inflammatory Bowel Disease.

Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease

P129 Anastomotic healing is functionally not impaired after ileocecal resection in a mouse model of Crohn's-like ileitis

Innate Lymphoid Cells and Inflammatory Bowel Disease

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease

Mesenteric Lymphatic B Cells Migrate to the Intestine and Aggravate DSS-Induced Colitis Via the CXCR5–CXCL13 Axis

Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits